Target species
Horses
Indications for use
Active immunisation of horses from 6 months of age against tetanus to prevent mortality.
Onset of immunity: | 2 weeks after the primary vaccination course |
Duration of immunity: | 17 months after the primary vaccination course |
| 2 years after the first revaccination |
Contraindications
None.
Special warnings for each target species
Foals should not be vaccinated before the age of 6 months, especially when born to mares that were revaccinated in the last two months of gestation, because of possible interference by maternally derived antibodies
Special precautions for use
Vaccinate healthy animals only.
Operator warning
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Special precautions for the protection of the environment
Not applicable.
Adverse reactions
Horses:
Rare (1 to 10 animals /10,000 animals treated): | Injection site swelling1, Injection site pain2. |
Very rare (<1 animal / 10,000 animals treated, including isolated reports): | Fever3, Lethargy3, Inappetence3, Hypersensitivity reaction4. |
1 A diffuse hard or soft swelling (max. diameter 5 cm), regressing within 2 days. A local reaction exceeding 5 cm and possibly persisting longer than 2 days may occur in very rare cases.
2 Pain at the injection site may result in temporary functional discomfort (stiffness).
3 Fever, sometimes accompanied by lethargy and inappetence, may occur for 1 day, and up to 3 days in exceptional circumstances.
4 Including anaphylaxis (sometimes fatal). If such a reaction occurs, appropriate treatment should be administered without delay.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See also the package leaflet for contact details.
Use during pregnancy or lactation
Can be used during pregnancy and lactation.
Interactions
Safety and efficacy data are available which demonstrate that this vaccine can be administered on the same day but not mixed with Tetanus Serum from MSD Animal Health (see section Amounts to be administered and administration route).
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the product mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Amounts to be administered and administration route
Intramuscular use.
Allow the vaccine to reach room temperature before use.
Vaccination schedule: Primary vaccination course Administer one dose (1ml), by intramuscular injection, according to the following schedule:
Primary vaccination course: first injection from 6 months of age, second injection 4 weeks later.
Revaccination:The first revaccination is given not later than 17 months after the primary vaccination course. Thereafter a maximum interval of two years is recommended (see schedule).
V1 | V2 | 5 | | 12 | V3 | 24 | V4 |
0 | 1 | | 6 | | 18 | | 42 months |
Equilis Te | Equilis Te | | | | Equilis Te | | Equilis Te |
In case of increased infection risk or insufficient colostrum intake, an additional initial injection can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 6 months of age and 4 weeks later)
Concurrent active and passive immunisation (emergency vaccination)
The vaccine can be used together with Tetanus Antitoxin Behring for treatment of injured horses that have not been immunised against tetanus. In that case, the first dose (V1) of vaccine can be given concurrently with the appropriate prophylactic dose of Tetanus Antitoxin Behring at a separate injection site, using separate syringes and needles. This will lead to a passive protection against tetanus for at least 21 days after concurrent administration. The second dose of the vaccine (V2) should be administered 4 weeks later. A third vaccination with Equilis Te should be repeated at least four weeks later. Concurrent use of Equilis Te and Tetanus Antitoxin Behring may reduce active immunity against tetanus compared to horses vaccinated with Equilis Te in the absence of tetanus antitoxin serum.
Overdose
Following the administration of a double dose of vaccine, no side effects other than those described under section "Adverse reactions" have been observed except for some depression at the day of vaccination.
Withdrawal periods
Zero days.